Status:
COMPLETED
Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy
Lead Sponsor:
Methodist Health System
Conditions:
Chronic Hepatic
Liver Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).
Detailed Description
The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC). This is...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Undergone EUS-guided liver biopsy at MDMC
Exclusion
- Below 18 years of age
- Did not undergo EUS-guided liver biopsy at MDMC
Key Trial Info
Start Date :
August 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04055870
Start Date
August 21 2017
End Date
October 30 2020
Last Update
June 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203